fusarium has been researched along with Pyrexia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CS; Hsiao, HH; Hsu, JF; Lin, SF; Liu, TC; Liu, YC; Lu, PL; Wu, CH | 1 |
| Camino, N; del Alcazar, E; Gancho, G; Jaka, A; Tuneu, A | 1 |
| Au-Yeung, R; Chan, TS; Chim, CS; Kwong, YL; Wong, SC | 1 |
| Chen, WT; Chen, YC; Hsiao, CH; Hsueh, PR; Ko, BS; Kuo, YM; Liu, JY; Yao, M | 1 |
| Menagé, Hdu P; Woolf, RT; Yeghen, T | 1 |
| Ergon, MC; Gülay, Z; Oren, H; Yücesoy, M | 1 |
| Ho, DY; Lee, JD; Montoya, JG; Rosso, F | 1 |
| Hachem, R; Raad, I | 1 |
| Bushelman, SJ; Callen, JP; Cohen, LM; Roth, DN | 1 |
2 review(s) available for fusarium and Pyrexia
| Article | Year |
|---|---|
Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
Topics: Adult; Alemtuzumab; Amphotericin B; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antineoplastic Agents; Combined Modality Therapy; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Fever; Fusariosis; Fusarium; Granulocytes; Humans; Immunocompromised Host; Leukocyte Transfusion; Lymphoma, T-Cell, Cutaneous; Male; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Skin Neoplasms; Triazoles; Voriconazole | 2011 |
Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Fever; Fusarium; Humans; Immunocompromised Host; Liposomes; Male; Mycoses; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2007 |
7 other study(ies) available for fusarium and Pyrexia
| Article | Year |
|---|---|
Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Fungal; Fatal Outcome; Female; Fever; Fusariosis; Fusarium; Humans; Idarubicin; Leukemia, Myeloid, Acute; Triazoles; Young Adult | 2014 |
Fever and skin lesions in an immunocompromised patient.
Topics: Fever; Fusariosis; Fusarium; Humans; Immunocompromised Host; Male; Middle Aged | 2015 |
Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia.
Topics: Adenine; Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fever; Fusariosis; Fusarium; Humans; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphadenopathy; Maintenance Chemotherapy; Male; Middle Aged; Neoplasm Recurrence, Local; Opportunistic Infections; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Remission Induction; Treatment Outcome | 2017 |
A rash in a patient with neutropenia.
Topics: Aged; Antifungal Agents; Dermatomycoses; Fever; Fusariosis; Fusarium; Humans; Leukemia, Myeloid, Acute; Male; Neutropenia; Triazoles | 2012 |
[Case report: a Fusarium fungaemia].
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Catheterization, Central Venous; Catheters, Indwelling; Child; Female; Fever; Fungemia; Fusarium; Humans; Immunosuppressive Agents; Itraconazole; Leukopenia; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2004 |
Treatment of central venous catheter-related fungemia due to Fusarium oxysporum.
Topics: Catheterization, Central Venous; Fever; Fungemia; Fusarium; Humans; Male; Middle Aged; Neutropenia; Triazoles | 1995 |
Disseminated Fusarium solani infection.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Dermatomycoses; Fatal Outcome; Female; Fever; Fungemia; Fusarium; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia | 1995 |